Winner Medical(SZ:300888) Sou Hu Cai Jing·2026-01-12 12:51Core Viewpoint - The company Steady Medical (300888) has shown significant growth in its financial performance, with a notable increase in revenue and net profit for the first three quarters of 2025 compared to the previous year [2]. Financial Performance - For the first three quarters of 2025, the company's main revenue reached 7.897 billion, reflecting a year-on-year increase of 30.1% [2]. - The net profit attributable to shareholders was 732 million, up 32.36% year-on-year [2]. - The net profit excluding non-recurring items was 679 million, marking a 43.93% increase year-on-year [2]. - In Q3 2025 alone, the company reported a single-quarter revenue of 2.601 billion, which is a 27.71% increase compared to the same quarter last year [2]. - The single-quarter net profit attributable to shareholders was 240 million, showing a year-on-year increase of 42.11% [2]. - The single-quarter net profit excluding non-recurring items was 218 million, reflecting a 50.77% increase year-on-year [2]. - The company's debt ratio stands at 33.87%, with investment income of 33.23 million and financial expenses of -2.036 million [2]. - The gross profit margin is reported at 48.32% [2]. Market Activity - As of January 12, 2026, the stock price closed at 39.73, with an increase of 1.43% [1]. - The trading volume was 59,800 hands, with a total transaction amount of 236 million [1]. - The net outflow of main funds was 2.9322 million, accounting for 1.24% of the total transaction amount [1]. - Retail investors showed a net inflow of 3 million, representing 1.27% of the total transaction amount [1]. Analyst Ratings - In the last 90 days, 22 institutions have provided ratings for the stock, with 18 buy ratings and 4 hold ratings [2]. - The average target price set by institutions over the past 90 days is 5.488 billion [2].